NTRB

Nutriband Inc. NASDAQ Listed Oct 1, 2021

Healthcare ·Biotechnology ·US · nutriband.com

$3.15

+2.94% vs $3.06

Mkt Cap $38.3M

52w Low $2.90 2.8% of range 52w High $11.68

50d MA $3.60 200d MA $4.81

P/E (TTM) —

EV/EBITDA —

P/B 5.5x

Debt/Equity 0.0x

ROE -123.2%

P/FCF -6.9x

RSI (14) 31.90

ATR (14) $0.19

Beta 1.93

50d MA $3.60

200d MA $4.81

Avg Volume 12.0K

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

SIC Code

3842

CIK (SEC)

1676047

Phone

407 377 6695

121 South Orange Avenue · Orlando, FL 32801 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 29, 2026	AMC	-1.89	-0.04	+97.9%	3.79	+0.0%	+2.1%	-0.3%	-4.1%	+10.3%	-2.7%	—
Dec 16, 2025	AMC	-2.13	-0.12	+94.4%	4.49	+2.0%	-2.0%	+3.0%	-0.9%	-2.4%	+3.4%	—
Sep 9, 2025	AMC	-0.17	-2.12	-1147.1%	6.08	+0.3%	-1.3%	+15.5%	+3.2%	-5.7%	+6.1%	—
May 30, 2025	AMC	-0.13	-0.12	+7.7%	6.50	+26.2%	+24.8%	-4.9%	+6.1%	-11.2%	+6.1%	—
Apr 28, 2025	AMC	-0.12	-0.18	-50.0%	5.84	-4.1%	-2.7%	+21.1%	-8.4%	+1.1%	+0.6%	—
Dec 3, 2024	AMC	—	-0.12	—	4.14	+7.0%	+5.1%	-6.4%	+1.2%	+0.0%	+14.3%	—
Sep 3, 2024	AMC	—	-0.12	—	4.71	-0.2%	-9.6%	-2.1%	+6.2%	-7.7%	-5.4%	—
May 31, 2024	AMC	—	-0.21	—	5.45	+1.8%	+13.0%	-3.7%	-15.0%	+6.0%	-2.6%	—
Apr 30, 2024	AMC	—	-0.16	—	3.46	-1.4%	+1.2%	+4.3%	-4.4%	-2.6%	-1.5%	—
Dec 12, 2023	AMC	—	-0.22	—	2.55	-3.1%	+4.7%	+0.0%	+0.0%	-4.9%	+0.8%	—
Sep 11, 2023	AMC	—	-0.11	—	2.85	+0.4%	-10.2%	+0.8%	+1.6%	+3.4%	-2.2%	—
Jun 9, 2023	AMC	—	-0.13	—	2.53	+0.8%	+8.3%	-1.5%	-1.9%	+4.2%	-5.8%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Jul 26	Small Cap Consumer Research	Maintains	Buy → Buy	—	$4.40	$4.48	+1.8%	+27.3%	+20.0%	-0.9%	-34.1%	-0.5%

Institutional (13F) — Top 8 All ↗

#	Manager	Shares	Value	Chg	Period
1	Vanguard Capital Management Llc	174,927	$617K	New	Mar 2026
2	Ubs Group Ag	32,664	$115K	Added	Mar 2026
3	Northern Trust Corp	13,945	$49K	—	Mar 2026
4	Haven Private, Llc	11,366	$40K	Reduced	Mar 2026
5	Morgan Stanley	7,000	$32K	—	Dec 2025
6	Wells Fargo & Company/mn	2,600	$9K	New	Mar 2026
7	Citigroup Inc	656	$3K	Reduced	Dec 2025
8	Northwestern Mutual Wealth Management Co	4	$18	New	Dec 2025

Mutual Funds / ETFs (N-PORT) — Top 5 All ↗

#	Fund	Shares	Value	Period
1	Fidelity Extended Market Index Fund	23,902	$106K	Feb 2026
2	Fidelity Total Market Index Fund	9,774	$43K	Feb 2026
3	Fidelity Nasdaq Composite Index Fund	8,237	$37K	Feb 2026
4	Fidelity Series Total Market Index Fund	7,231	$32K	Feb 2026
5	iShares Micro-Cap ETF	8,932	$32K	Mar 2026

Data updated apr 26, 2026 4:01pm · Source: financialmodelingprep.com